Artificial‑intelligence startup Anthropic and medical‑knowledge platform OpenEvidence announced a joint effort to bring free, AI‑powered clinical decision support to physicians in about 100 low‑ and middle‑income countries. The collaboration, unveiled on Tuesday, seeks to give clinicians in regions such as Uganda, Angola, Sudan, Haiti and Mongolia instant access to peer‑reviewed research and treatment guidelines via smartphones.
How the service works
OpenEvidence answers doctors’ questions by drawing on a curated database of peer‑reviewed medical literature and established treatment protocols. In the United States and Europe the platform is already free for clinicians, and the new initiative extends that model worldwide. Anthropic will supply the underlying generative‑AI technology, while OpenEvidence tailors the interface and content to local health‑system realities, accounting for differences in disease patterns, diagnostic resources and available therapies.
Local impact and early adoption
According to OpenEvidence founder Daniel Nadler, U.S. clinicians consulted the platform 42 million times in August alone. He projects that by the end of 2026 several hundred million patients worldwide will have been treated by doctors who used OpenEvidence to inform care decisions. “Access to medical knowledge shouldn’t depend on geography,” Nadler said, emphasizing that even in facilities without reliable electricity, most physicians have smartphones capable of running the service.
Support and criticism
Proponents argue that AI tools can help clinicians quickly navigate the ever‑growing body of medical information, easing the burden on overstretched health workers and improving patient outcomes. Critics caution that generative‑AI models trained primarily on data from high‑income countries may not fully reflect local practice conditions or resource constraints. The partnership addresses those concerns by making the system “context adaptive,” according to Nadler, ensuring that recommendations consider regional treatment availability and infrastructure.
Broader AI‑in‑healthcare landscape
Health systems worldwide are exploring whether generative AI can mitigate physician shortages and support specialist‑level decision‑making. While some executives and lawmakers have called for a slowdown in AI development due to safety and ethical worries, the Anthropic‑OpenEvidence effort demonstrates a focused, humanitarian application of the technology. Neither company disclosed financial terms of the collaboration.
Looking ahead
OpenEvidence has already begun adapting its tools for use in Rwanda and Botswana, where disease patterns and diagnostic capabilities differ markedly from wealthier nations. Dr. Ahmed Bendary, a cardiologist at Benha University in Egypt, praised the expansion, calling it “a tremendous leap forward” for regions where institutional subscriptions to major medical journals are limited. As the rollout progresses, the partnership aims to empower clinicians everywhere with reliable, evidence‑based guidance at the point of care.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
